Equillium, Inc. (EQ) Financials
EQ Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 43.6 million | 22.5 million |
| 2023-12-31 | 50.5 million | 28.0 million |
| 2023-09-30 | 55.2 million | 31.1 million |
| 2023-06-30 | 58.8 million | 31.8 million |
EQ Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -8.8 million | 972000 |
| 2023-12-31 | -5.7 million | 1.0 million |
| 2023-09-30 | -1.9 million | 979000 |
| 2023-06-30 | -6.2 million | 934000 |
EQ Net Income
No data available :(
EQ Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 32.3 million | - | 719000 |
| 2023-12-31 | 40.9 million | - | 824000 |
| 2023-09-30 | 46.3 million | - | 926000 |
| 2023-06-30 | 48.4 million | - | 1.0 million |
EQ Shares Outstanding
EQ Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 19000 | 9.7 million | 3.7 million | -32000 |
| 2023-12-31 | 35000 | 9.2 million | 3.2 million | -32000 |
| 2023-09-30 | 15000 | 9.0 million | 3.5 million | - |
| 2023-06-30 | 15000 | 9.6 million | 3.1 million | - |
EQ Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 10.7 million | 32000 |
| 2023-12-31 | 9.2 million | 33000 |
| 2023-09-30 | 8.9 million | 31000 |
| 2023-06-30 | 9.1 million | 31000 |
EQ
Price: $1.56
52 week price:
Earnings Per Share: -0.35 USD
P/E Ratio: -7.64
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 25774
Market Capitalization: 54.3 million